Rina was the first patient treated by the clinical team of Hadassah Medical Center using the FDA-cleared P-Cure Proton Therapy solution. “The solution is the most compact comprehensive proton therapy system that simulates, plans, positions, and treats with enhanced patient comfort and clinical results, treating all indications with adaptive, personalized proton therapy protocols,†said P-Cure CEO Dr. Michael Marash, adding the unique advantage that the entire P-Cure system is installed in a conventional size treatment room.

Treatment of cancer with proton therapy is considered the gold standard for treating many types of cancer sites with unique clinical capabilities. However, current legacy technology requires proton equipment weighing 200 tons, and with a cost exceeding $50 million per single room including equipment and construction. This has significantly limited the establishment of proton therapy services at most cancer care facilities globally and the availabilit y of this crucial type of treatment to those in need. Until today, only less than 1% of hospitals offer proton therapy to their patients. P-Cure significantly reduces the size and cost of the proton therapy equipment. “The P-Cure Solution fits within the space of conventional and existing Linac vaults. In many cases, our system virtually eliminates all construction costs, making the clinical benefits of proton therapy, as well as the benefits of a patient centric seated position treatment system, available to virtually all cancer treatment centers," said Dr. Marash.

About P-Cure:
P-Cure, an Israel-based company, develops and supplies the most compact Proton Therapy solution for the targeted treatment of cancer with radiation.

Back to HCB News

Rad Oncology Homepage